<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7425093\results\search\drug\results.xml">
  <result pre="effective against SARS-CoV-2. Remdesivir is a phosphoramidate prodrug of an" exact="adenosine" post="C-nucleoside. By entrance into respiratory epithelial cells in human,"/>
  <result pre="RNA-dependent RNA polymerase (RdRp) by competing with the usual counterpart" exact="adenosine" post="triphosphate (ATP). The nucleoside analog is incorporated into the"/>
  <result pre="including ribavirin, favipiravir, penciclovir, galidesivir, remdesivir, 6Ê¹-fluorinated aristeromycin analogs and" exact="acyclovir" post="fleximer analogs are available.4 In clinical trials associated with"/>
  <result pre="Mechanism of Action Remdesivir is a phosphoramidate prodrug of an" exact="adenosine" post="C-nucleoside (Figure 1A).12 By entrance into respiratory epithelial cells"/>
  <result pre="structures of (A) remdesivir as the phosphoramidate prodrug of an" exact="adenosine" post="C-nucleoside and (B) pharmacologically active nucleoside triphosphate (NTP) as"/>
  <result pre="RNA-dependent RNA polymerase (RdRp) by competing with the usual counterpart" exact="adenosine" post="triphosphate (ATP). The nucleoside analog is incorporated into the"/>
  <result pre="and inhibits the enzyme by competing with the usual counterpart" exact="adenosine" post="triphosphate (ATP). The nucleoside analog is incorporated into the"/>
  <result pre="Results of data screening showed that GS-441,524 (a 1Ê¹-CN modified" exact="adenosine" post="C-nucleoside hit) along with GS-5734 (a prodrug form of"/>
  <result pre="remdesivir and interferon-beta have a superior antiviral activity compared to" exact="lopinavir" post="and ritonavir against MERS-CoV in vitro. In mice, both"/>
  <result pre="interferon-beta have a superior antiviral activity compared to lopinavir and" exact="ritonavir" post="against MERS-CoV in vitro. In mice, both prophylactic and"/>
  <result pre="clinical trial focused on evaluating simultaneous administration of remdesivir and" exact="dexamethasone" post="in patients on ventilators with COVID-19. The World Health"/>
  <result pre="initial clinical trial results from the United Kingdom that showed" exact="dexamethasone" post="could reduce mortality by one-third in patients on ventilators"/>
  <result pre="ventilators with COVID-19. For patients requiring only oxygen, administration of" exact="dexamethasone" post="decreased the mortality rate by about one-fifth.42 Evaluating the"/>
  <result pre="by about one-fifth.42 Evaluating the efficacy of remdesivir along with" exact="dexamethasone" post="in patients on ventilators with COVID-19 may be interesting."/>
  <result pre="Discovery and synthesis of a phosphoramidate prodrug of a Pyrrolo[2,1-f][triazin-4-amino]" exact="adenine" post="C-nucleoside (GS-5734) for the treatment of Ebola and emerging"/>
  <result pre="Med. 2017;9(396):eaal3653. doi:10.1126/scitranslmed.aal365328659436 18.WangM, CaoR, ZhangL, et al. Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 </snippets>
</snippetsTree>
